The UK drugs regulator has removed postoperative pain from prolonged-release opioid licences due to increased risks of ...

After six years at the helm of the Medicines and Healthcare products Regulatory Agency (MHRA), Dame June Raine will step down ...

The MHRA welcomed Health Minister Smyth to its science campus as part of British Science Week to demonstrate how innovations ...

Vertex announced that the United Kingdom Medicines and Healthcare products Regulatory Agency has granted approval for ALYFTREK, a once-daily ...

RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced its plan to submit a UK Marketing Authorisation Application (MAA) for Talicia ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Alyftrek (triple combination medicine ...

Johnson & Johnson’s (J&J) Lazcluze (lazertinib) has been approved by the Medicines and Healthcare products Regulatory Agency ...

Dopamine-receptor agonists, used to treat Parkinson's disease and restless legs syndrome, have been linked to impulse-control disorders like hypersexuality and compulsive gambling. Studies highlight ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Lazcluze (lazertinib) for adults with non-small ...

The former minister, who was chancellor of the Duchy of Lancaster (CDL), denied seeking to pressure the Medicines and Healthcare products Regulatory Agency (MHRA) to approve the product as he gave ...